Andrew B. Gladden
- Molecular Biology top 10%
- Oncology top 5%
- Cell Biology top 2%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Co-authors
- J. Alan DiehlAndrea I. McClatcheyFengmin LuJodi R. AltMariusz A. WasikEveline E. SchneebergerPriya AggarwalMarco Giovannini
- Topics
- Cancer-related Molecular Pathways (10 papers)Hippo pathway signaling and YAP/TAZ (6 papers)Microtubule and mitosis dynamics (5 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Andrew B. Gladden
23 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 1.1k
- Oncology 724
- Cell Biology 575
- Pulmonary and Respiratory Medicine 209
- Cancer Research 178
Countries citing papers authored by Andrew B. Gladden
This map shows the geographic impact of Andrew B. Gladden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew B. Gladden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew B. Gladden more than expected).
Fields of papers citing papers by Andrew B. Gladden
This network shows the impact of papers produced by Andrew B. Gladden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew B. Gladden. The network helps show where Andrew B. Gladden may publish in the future.
Co-authorship network of co-authors of Andrew B. Gladden
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew B. Gladden. A scholar is included among the top collaborators of Andrew B. Gladden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew B. Gladden. Andrew B. Gladden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 22 | |
| 6 | 11 | |
| 7 | 13 | |
| 8 | 10 | |
| 9 | 22 | |
| 10 | 100 | |
| 11 | 26 | |
| 12 | 40 | |
| 13 | 49 | |
| 14 | 205 | |
| 15 | 61 | |
| 16 | 105 | |
| 17 | 104 | |
| 18 | 56 | |
| 19 | 61 | |
| 20 | 161 |
About Andrew B. Gladden
Andrew B. Gladden is a scholar working on Cell Biology, Oncology and Molecular Biology, having authored 26 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Microtubule and mitosis dynamics (5 papers). The work is most often cited by research in Cell Biology (575 citations), Oncology (724 citations) and Molecular Biology (1.1k citations). Andrew B. Gladden has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include J. Alan Diehl, Andrea I. McClatchey, Fengmin Lu, Jodi R. Alt, Mariusz A. Wasik, Eveline E. Schneeberger, Priya Aggarwal, Marco Giovannini, Marcello Curto and Ichiko Saotome. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.